PPD in the News
The value of predictive analytical applications as digital health tools
Thomas Healy discusses the emerging benefits and capabilities of predictive analytic applications supported by wearable sensor devices.
Functional service partnerships: Speeding seamless implementation
Lisa Beckel discusses keys to implementing an FSP partnership, addressing some of the challenges, and how to assure efficient onboarding and resourcing for FSP clinical research projects.
Strategies for 21st Century Patient Recruitment
The authors examine emerging trends in patient recruitment and how best to optimize them.
AI in unexpected places: How ML and NLP improve startup timelines
The authors discuss how new applications of machine learning and natural language processing are having a profound impact on clinical trial agility and accuracy.
Thermo Fisher continues to expand clinical research capacity with $59m lab expansion
The current 71,600-square-foot operation will grow to 114,000 square feet and be completed in stages by the end of 2024, creating 200 new jobs over the next five years.
Thermo Fisher Scientific to invest $59 million with Campbell Co. expansion
Much of the expansion involves adding to the business’ sample management and testing capacity to support new therapeutics, including vaccines and cell and gene therapy products.
Thermo Fisher adds clinical research lab as part of $97m expansion
The bulk of the expansion with this new facility will occur in liquid chromatography-mass spectrometry for drug discovery through to clinical testing.
PPD launches decentralized trial certification program for sites and investigators
New network will be available to the full range of sites that the business currently works with to deliver DCT studies for customers.
Thermo Fisher Launches Decentralized Clinical Trial Network
New network to support global investigators and research sites participating in decentralized clinical trials for pharmaceutical and biotech customers.